Role of Tumor Necrosis Factor-alpha and Its Receptors in Human Benign Breast Lesions and Tumors (in Situ and Infiltrative)

Overview

Journal Cancer Sci

Specialty Oncology

Date 2006 Sep 21

PMID 16984377

Citations 30

Authors

Ignacio Garcia-Tunon

Monica Ricote

Antonio Ruiz

Benito Fraile

Ricardo Paniagua

Mar Royuela

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to characterize the expression pattern of tumor necrosis factor (TNF)-alpha and its receptors in breast samples (benign diseases, in situ carcinomas and infiltrating carcinomas), and to compare these results with those obtained previously for interleukin-6, p53 and p21 using the same samples in order to elucidate the effects of these cytokines on the proliferation-apoptosis equilibrium. Immunoexpression of TNF-alpha and its receptors (TNFRI and TNFRII) were studied by western blotting and immunohistochemistry. The percentage of samples positive for TNF-alpha and TNFRII was higher in in situ carcinoma than in benign breast diseases, and TNFRII was even higher in infiltrating tumors. The percentage of samples positive for TNFRI was similar in the three groups. For the three proteins and in the three patient groups, immunoreactions were observed in the peripheral cytoplasm. In the positive samples, immunostaining for TNF-alpha was more intense in infiltrating tumors than in the other two patient groups, whereas immunostaining for both receptors was higher in in situ carcinoma than in benign breast diseases, and even higher in infiltrating tumors. Comparing the TNF-alpha results with previous results for mtp53, p21 and interleukin-6, we found an association between the expression of these four proteins and increasing malignancy. TNF-alpha might be an important factor in breast cancer promotion as its proliferation and survival effects seems to be enhanced through the increased expression of TNFRII. Also, the pro-apoptotic pathway of TNFRI could be inhibited by p21 (which appeared increased in breast cancer), altering TNFRI effects in promoting the expression of several factors, such interleukin-6, which contribute to tumor promotion.

Citing Articles

Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.

Mussa A, Ismail N, Hamid M, Al-Hatamleh M, Bragoli A, Hajissa K J Exp Clin Cancer Res. 2024; 43(1):312.

PMID: 39609700 PMC: 11603874. DOI: 10.1186/s13046-024-03218-1.

Apoptosis-Cell Cycle-Autophagy Molecular Mechanisms Network in Heterogeneous Aggressive Phenotype Prostate Hyperplasia Primary Cell Cultures Have a Prognostic Role.

Matei E, Enciu M, Rosu M, Voinea F, Mitroi A, Deacu M Int J Mol Sci. 2024; 25(17).

PMID: 39273277 PMC: 11394677. DOI: 10.3390/ijms25179329.

Targeting inflammation as cancer therapy.

Wang M, Chen S, He X, Yuan Y, Wei X J Hematol Oncol. 2024; 17(1):13.

PMID: 38520006 PMC: 10960486. DOI: 10.1186/s13045-024-01528-7.

Honey: A Promising Therapeutic Supplement for the Prevention and Management of Osteoporosis and Breast Cancer.

Martiniakova M, Kovacova V, Mondockova V, Zemanova N, Babikova M, Biro R Antioxidants (Basel). 2023; 12(3).

PMID: 36978815 PMC: 10045300. DOI: 10.3390/antiox12030567.

A Milk-Fat Based Diet Increases Metastasis in the MMTV-PyMT Mouse Model of Breast Cancer.

Velazquez F, Viscardi V, Montemage J, Zhang L, Trocchia C, Delamont M Nutrients. 2021; 13(7).

PMID: 34371939 PMC: 8308868. DOI: 10.3390/nu13072431.

References

De Miguel M, Royuela M, Bethencourt F, Santamaria L, Fraile B, Paniagua R . Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate. Cytokine. 2000; 12(5):535-8. DOI: 10.1006/cyto.1999.0585. View

Fiers W . Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991; 285(2):199-212. DOI: 10.1016/0014-5793(91)80803-b. View

Diab S, Yu Y, Hilsenbeck S, Allred D, Elledge R . WAF1/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat. 1997; 43(2):99-103. DOI: 10.1023/a:1005752829260. View

Liu Z, Hsu H, Goeddel D, Karin M . Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 1996; 87(3):565-76. DOI: 10.1016/s0092-8674(00)81375-6. View

Hubel K, Mansmann G, Schafer H, Oberhauser F, Diehl V, Engert A . Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF. Cytokine. 2000; 12(12):1797-800. DOI: 10.1006/cyto.2000.0780. View

Sukhikh G, Zhdanov A, Davydova M, Slukina T, Chernukha G, Samoilova T . Disorders in cytokine gene expression in endometrial hyperplasia and effect of hormone therapy. Bull Exp Biol Med. 2005; 139(2):235-7. DOI: 10.1007/s10517-005-0257-7. View

Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun K, Bulun S . Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma:.... Cancer Res. 2001; 61(5):2250-5. View

Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K . Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000; 6(8):3282-9. View

Engelmann H, Novick D, Wallach D . Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem. 1990; 265(3):1531-6. View

10.

Zubelewicz B, Muc-Wierzgon M, Wierzgon J, Romanowski W, Mazurek U, Wilczok T . Genetic disregulation of gene coding tumor necrosis factor alpha receptors (TNF alpha Rs) in follicular thyroid cancer--preliminary report. J Biol Regul Homeost Agents. 2002; 16(2):98-104. View

11.

Loetscher H, Pan Y, Lahm H, Gentz R, Brockhaus M, Tabuchi H . Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 1990; 61(2):351-9. DOI: 10.1016/0092-8674(90)90815-v. View

12.

Scott K, Arnott C, Robinson S, Moore R, Thompson R, Marshall J . TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?. Oncogene. 2004; 23(41):6954-66. DOI: 10.1038/sj.onc.1207915. View

13.

Tartaglia L, WEBER R, Figari I, Reynolds C, Palladino Jr M, Goeddel D . The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A. 1991; 88(20):9292-6. PMC: 52700. DOI: 10.1073/pnas.88.20.9292. View

14.

Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M . IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Histopathology. 2005; 47(1):82-9. DOI: 10.1111/j.1365-2559.2005.02178.x. View

15.

Wang X, Li N, Li H, Liu B, Qiu J, Chen T . Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest. Clin Cancer Res. 2005; 11(20):7545-53. DOI: 10.1158/1078-0432.CCR-05-0879. View

16.

Flynn J, GOLDSTEIN M, Chan J, Triebold K, Pfeffer K, Lowenstein C . Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995; 2(6):561-72. DOI: 10.1016/1074-7613(95)90001-2. View

17.

CARSWELL E, Old L, Kassel R, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMC: 433057. DOI: 10.1073/pnas.72.9.3666. View

18.

Tartaglia L, Goeddel D . Two TNF receptors. Immunol Today. 1992; 13(5):151-3. DOI: 10.1016/0167-5699(92)90116-O. View

19.

Mestiri S, Bouaouina N, Ben Ahmed S, Chouchane L . A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma. Cytokine. 2005; 30(4):182-7. DOI: 10.1016/j.cyto.2005.01.007. View

20.

Zhan Y, Kelso A, Cheers C . Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Immunology. 1993; 80(3):458-64. PMC: 1422217. View